Texto: 
24 hour urine lab values
       METANEPHRINE. . . . .  4764                                  ug/L
       METANEPHRIN 24H . . .  7146                   (45-290)       ug/24hr
       NORMETANEPHRINE . . .  3052                                  ug/L
       NORMETA 24H . . . . .  4578                   (82-500)       ug/24hr
       METANEPH TOT 24 . .   11724                  (120-700)       ug/24hr
      EPINEPHRINE 24H . . .   407                  (0.5-20.0)      ug/24 Hr
       NOREPINEPHRINE. . . .   422                                  ug/L
       NOREPI 24H. . . . . .   633                   (15-80)        ug/24 Hr
      CORTSL PT CHA . . . . .  36.2     H          (5.0-18.0)      ug/dL
Surgical resection of mass
CT demonstrates a large left adrenal mass without calcification on the non-contrast CT.  The tumor has heterogenous enhancement with central necrotic area.
Pheochromocytoma (Path proven)
<i>Pheochromocytoma
<i>Adrenocortical Carcinoma
<i>Metastasis
<i>Lipid-poor adenoma [on the unenhanced CT (27HU)]
Hypertension and episodic headaches, palpitations, and diaphoresis.


Keywords: 
\-\ l\\ normeta\\ 24h\ \(0\)\
\-\ l\\ norepi\\ 24h\ \(0\)\
\-\ l\\ metanephrin\\ 24h\ \(0\)\
\-\ 24hr\\ epinephrine\\ 24h\ \(0\)\
\-\ 24hr\\ metaneph\\ tot\\ 24\ \(0\)\
\-\ mass\\ ct\\ demonstrates\ \(0\)\
\-\ 4764\\ ug\ \(0\)\
\-\ 422\\ ug\ \(0\)\
\-\ 3052\\ ug\ \(0\)\
\-\ unenhanced\\ ct\ \(0\)\
\-\ ug\ \(3855\)\
\-\ contrast\\ ct\ \(0\)\
\-\ 24hr\\ normetanephrine\ \(0\)\
\-\ 24\\ hr\\ norepinephrine\ \(0\)\
\-\ dl\\ surgical\\ resection\ \(0\)\
\-\ central\\ necrotic\\ area\ \(2\)\
\-\ 27hu\\ \\)\\]\\ hypertension\ \(0\)\
\-\ poor\\ adenoma\ \(1\)\
\-\ path\\ proven\ \(4\)\
\-\ heterogenous\\ enhancement\ \(5\)\
\-\ episodic\\ headaches\ \(1\)\
\-\ adrenocortical\\ carcinoma\ \(1\)\
\-\ 2\\ h\ \(143\)\
\-\ tumor\ \(1901\)\
\-\ pheochromocytoma\ \(23\)\
\-\ palpitations\ \(22\)\
\-\ non\ \(1889\)\
\-\ metastasis\ \(206\)\
\-\ lipid\ \(65\)\
\-\ diaphoresis\ \(12\)\
\-\ 82\ \(193\)\
\-\ 80\ \(384\)\
\-\ 7146\ \(1\)\
\-\ 700\ \(19\)\
\-\ 633\ \(3\)\
\-\ 500\ \(61\)\
\-\ 5\ \(8237\)\
\-\ 4578\ \(1\)\
\-\ 45\ \(319\)\
\-\ 407\ \(7\)\
\-\ 36\ \(281\)\
\-\ 290\ \(3\)\
\-\ 20\ \(2416\)\
\-\ 18\ \(533\)\
\-\ 15\ \(862\)\
\-\ 120\ \(51\)\
\-\ 11724\ \(1\)\
\-\ 0\ \(11370\)\
